日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome

晚期 Sézary 综合征中 TNFR2 拮抗抗体靶向杀死表达 TNFR2 的肿瘤细胞和 Treg

H Torrey, M Khodadoust, L Tran, D Baum, A Defusco, Y H Kim, D L Faustman

Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial

吉西他滨联合曲妥珠单抗和帕妥珠单抗治疗既往接受过帕妥珠单抗治疗的人表皮生长因子受体2阳性转移性乳腺癌患者的疗效和安全性:一项II期临床试验

Iyengar, Neil M; Smyth, Lillian M; Lake, Diana; Gucalp, Ayca; Singh, Jasmeet C; Traina, Tiffany A; DeFusco, Patricia; Fornier, Monica N; Goldfarb, Shari; Jhaveri, Komal; Modi, Shanu; Troso-Sandoval, Tiffany; Patil, Sujata; Ulaner, Gary A; Jochelson, Maxine; Norton, Larry; Hudis, Clifford A; Dang, Chau T

OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections

OG716:设计一种适用于治疗艰难梭菌感染的兰替抗生素

Kers, Johan A; DeFusco, Anthony W; Park, Jae H; Xu, Jin; Pulse, Mark E; Weiss, William J; Handfield, Martin